featured
FDA Approves Miplyffa for Treatment of Niemann-Pick Disease, Type C
Miplyffa is the first drug approved for treating associated neurological symptoms in adults and children 2 years and older
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.